CAN-10

N/A

Report date: 2026/02/06 20:01:23

Base Information

Drug NameCAN-10
Drug Alias NameCAN-10
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-33 inhibitorsInterleukin-1 alpha inhibitorsInterleukin-36 alpha inhibitors
TargetsInterleukin-33Interleukin-1 alphaInterleukin-36 alpha
Therapy Area/IndicationsPlaque psoriasisScleroderma, SystemicMyocarditis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLund University Foundation
China Registration ClassN/A

Develop Information

Active CompaniesOtsuka Pharmaceutical Development & Commercialization IncOtsuka Pharmaceutical Co LtdLund University Foundation
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisScleroderma, SystemicMyocarditis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A